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S100 proteins are calcium-responsive signaling proteins
that are overexpressed in cancer and in£ammatory dis-
eases. They act by forming complexes with target pro-
teins to modify target protein function. Identifying
S100 intracellular distribution, site of action, and pro-
tein targets are important goals. S100A7 (psoriasin) is
an important member of this family that is markedly
overexpressed in psoriatic keratinocytes; however, its
role in disease progression is poorly understood. In this
study, we express S100A7 in normal keratinocytes as a
means to study S100A7 function.We show that S100A7
is present in the cytosol and in BiP/GRP78-positive
(endoplasmic reticulum) tubular structures.When cells
are challenged with elevated intracellular calcium, cy-
toplasmic S100A7 redistributes to a-actinin- and paxil-
lin-positive peripheral structures that contact the
substrate surface. Epidermal fatty acid binding protein
is also overexpressed in psoriasis, and is a putative target
of S100A7 in keratinocytes.To study this interaction, we
coexpressed S100A7 and epidermal fatty acid binding
protein. These studies indicate that S100A7 and epider-
mal fatty acid binding protein colocalize in the cyto-
plasm in untreated cultures, and localize in peripheral
structures in response to calcium challenge. In addition,
S100A7 expression appears to stabilize epidermal fatty
acid binding protein level, and vice versa. Moreover,
the proteins can be coprecipitated in the presence of bi-
functional cross-linker, suggesting that they are part of
a common complex. The colocalization with a-actinin
and paxillin suggests that S100A7 and epidermal fatty
acid binding protein colocalize in focal adhesion-like
structures following calcium treatment. Key words: epi-
dermal fatty acid binding protein/keratinocyte di¡erentiation/
psoriasin/psoriasis/signal transduction. J Invest Dermatol
121:132 ^141, 2003
T
he S100 proteins comprise a family of EF hand
proteins that exist as noncovalently linked homodi-
mers and heterodimers (Donato, 1999). Calcium
binding to the EF hands exposes hydrophobic do-
mains, and results in S100 protein activation. The
calcium-activated S100 dimer then interacts with speci¢c target
proteins. This interaction alters target protein function
(Heizmann and Cox, 1998; Donato, 1999). By this mechanism,
S100 proteins regulate cell structure, shape, proliferation, and
di¡erentiation (Heizmann and Cox, 1998; Donato, 1999). These
proteins are thought to be important in epidermal di¡erentiation,
as selected members are expressed in epidermis (Ho¡mann et al,
1994; Tavakkol et al, 1994; Boni et al, 1997) and the corresponding
genes are clustered in the epidermal di¡erentiation complex
at chromosomal location 1q21 (Engelkamp et al, 1993). Moreover,
they are activated by calcium (Donato, 1999), an important
regulator of keratinocyte terminal di¡erentiation (Eckert et al,
1997). S100A7, also called psoriasin, is expressed at very low
levels in normal skin and in cultured keratinocytes; however,
expression is markedly increased in hyperproliferative skin dis-
eases, such as psoriasis, suggesting that S100A7 may play a part
in disease pathogenesis (Madsen et al, 1991, 1992; Ho¡mann
et al, 1994; Algermissen et al, 1996). The role of S100A7 in psoria-
sis is not well understood; however, a putative S100A7
interaction partner, epidermal fatty acid binding protein
(EFABP), has been identi¢ed in extracts from psoriatic epidermis
(Hagens et al, 1999a, b). Like S100A7, EFABP is overexpressed in
psoriatic epidermis (Siegenthaler et al, 1994; Hagens et al, 1999a).
In this study we utilize adenoviral expression vectors to express
S100A7 and EFABP in cultured normal human keratinocytes as a
model to study the localization, distribution, and interaction of
these proteins. Our results suggest that S100A7 and EFABP interact,
are codistributed within cells, and redistribute to structures at the
cell periphery following calcium stimulus. Co-localization with
paxillin and a-actinin identify these as adhesion plaque-like periph-
eral structures. Okadaic acid also promotes this redistribution, sug-
gesting that the process involves a phosphatase-sensitive kinase.
MATERIALS ANDMETHODS
Cell culture Passage three foreskin keratinocytes were maintained in
keratinocyte serum free-medium, supplemented with pituitary extract
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and epidermal growth factor. All human tissue samples were collected
respecting the Helsinki Principles.
Adenovirus construction For S100A7 adenovirus construction,
primers (50 -GCGAATTCATGAGCAACACTCAAGCTGAG (upstream)
and 50 -TAGGATCCTGGGTCTC TGGAGGCCCATTG (downstream)
were used in a polymerase chain reaction using pET28-S100A7 plasmid
(Ruse et al, 2001) as template. The underlined sequences in the primers
designate a EcoRI and a BamHI restriction sites. The resulting
polymerase chain reaction product was cloned into pZERO, sequenced,
and the S100A7 insert was excised using EcoRI and BamHI, and
transferred to EcoRI/BamHI-restricted pCA3 (Microbix Biosystems,
Toronto, Canada). pCA3 contains a CMV promoter and an SV40
polyadenylation signal. The resulting plasmid, pCA3-S100A7, was
cotransfected with pJM17 adenovirus backbone vector (Microbix
Biosystems) into 293 cells. After recombination, selected plaques were
isolated, puri¢ed, and ampli¢ed in 293 cells to yield Ad5-S100A7. For
EFABP adenovirus construction, human RNA was isolated from human
keratinocytes, reverse transcribed using a ¢rst strand cDNA synthesis kit
(Roche Biochemicals, Indianapolis, IN, USA), and the resulting single-
stranded cDNA was ampli¢ed in a polymerase chain reaction using
EFABP speci¢c primers (50 -TTGAATTCATGGCCACAGTTCAGCAGC,
upstream; 50 -CGTCTAGATTATTCTACTTTTTCATAGATCC, down-
stream). The EcoRI and XbaI restriction sites are underlined. The
polymerase chain reaction product was subcloned to pZERO and
sequenced. The EFABP cDNA was excised using EcoRI/XbaI and
transferred to EcoRI/XbaI-restricted pCA3 to create pCA3-EFABP. Co-
transfection of 293 cells with pCA3-EFABP and pJM17 yielded
recombinant virus, Ad5-EFABP.
To add the HA epitope at the amino-terminus of S100A7 or EFABP,
HA-encoding complementary oligonucleotides (50 -TCGACATGTA-
CCCATACGACGTCCCAGACTACGCTG and 50 -AATTCAGCGTAGT-
CTGGGACGTCGTATGGGTACATG) were synthesized. The underlined
sequences contain partial SalI and EcoRI sites that were used to insert the
HA sequence at the amino terminus of S100A7 and EFABP to create
pCA3-HA-S100A7 and pCA3-HA-EFABP. Using an identical approach,
FLAG-S100A7 and FLAG-EFABP viruses were produced using FLAG-
encoding complimentary oligonucleotides 50 -TCGACATGGACTACA-
AGGACGACGACGACAAGG and 50 -AATTCCTTGTCGTCGTCGTC
CTTGTAGTCCATG. The underlined sequences identify partial SalI and
EcoRI restriction sites that were used to insert the FLAG sequence. The
resulting adenoviruses include Ad5-S100A7, Ad5-EFABP, Ad5-HA-
S100A7, Ad5-HA-EFABP, Ad5-FLAG-S100A7, and Ad5-FLAG-EFABP.
Keratinocytes were treated at adenovirus infection levels (multiplicity of
infection, MOI¼viral particles per cell) designed to infect a high
percentage of cells (490%) without causing virus-dependent toxicity.
The percent of cells infected was evaluated using a vector, Ad5-GFP,
which encodes green £uorescent protein (Dashti et al, 2001).
Immunoprecipitation Near-con£uent keratinocyte cultures, grown in
ten 50 cm2 dishes in keratinocyte serum free medium, were infected with
the appropriate S100A7- or EFABP-encoding adenoviruses in the presence
of 2.5 mg polybrene per mL. After 24 h, the medium was replaced with
10mL of fresh keratinocyte serum free medium, and the cells were
incubated for 24 h. The cells were then washed with phosphate-bu¡ered
saline (PBS) and treated for 60min with 1mM of the bifunctional cross-
linkers, dithiobis(succinimidylpropionate) (DSP) or disuccinimidyl
suberate (DSS), obtained from Pierce (Pierce, Rockford, IL, USA), and
then washed and scraped into 1mL of PBS and centrifuged. The pellet
was resuspended in 500 mL of lysis bu¡er (20mM Tris, pH 7.4, 150mM
NaCl, 1mM ethylenediamine tetraacetic acid, 1mM ethyleneglycol-bis-(b-
aminoethylether)-N,N,N0,N0-tetraacetic acid, 1% Triton, 2.5mM sodium
pyrophosphate, 1mM b-glycerolphosphate, 1mM Na3VO4, 1 mg per mL
leupeptin, 1mM phenylmethylsulfonyl £uoride) and sonicated. Disrupted
cells were centrifuged at 14,000 g at 41C, and the supernatant was saved
as whole cell lysate. Protein concentrations were determined by Bradford
assay.
One milligram of total protein was incubated with rabbit anti-S100A7
antibody, rat anti-HA high a⁄nity antibody (Roche Biochemicals, 1.5 mg),
or mouse anti-FLAG (Sigma, 5 mg) (Sigma-Aldrich St. Louis, MO, USA)
for 3 h at 41C. Protein^antibody complexes were then precipitated with
protein (AþG)-agarose (SantaCruz Biotechnology, Santa Cruz, CA,
USA) for 1h at 41C. Precipitates were washed three times with lysis
bu¡er, resuspended in 50 mL Laemmli sample bu¡er and boiled for 5min.
The precipitated samples were electrophoresed, in parallel, with 20 mg of
whole cell lysate on a 15% acrylamide gel, and the proteins were
transferred to PVDF membrane. For S100A7 detection, the blots were
incubated with polyclonal rabbit anti-S100A7 antibody (1:1000) overnight,
washed, and then incubated with horseradish peroxidase-conjugated
donkey anti-rabbit IgG (Amersham, 1:10,000) (Amersham, Piscataway, NJ,
USA) for 1h. For HA-EFABP detection, the blots were incubated with
horseradish peroxidase-conjugated rat anti-HA (Roche, 1:400) for 1h. For
detection of S100A9, the blots were incubated with goat anti-S100A9
(Santa Cruz, 1:500) followed by horseradish peroxidase-conjugated
donkey anti-goat IgG (Santa Cruz, 1:10,000). All blots were washed
thoroughly after incubation with the secondary antibody and exposed to
ECL detection reagents (Amersham).
Immuno£uorescence Keratinocytes were plated on glass coverslips, and
infected with either Ad5-HA-S100A7 (15 MOI) or Ad5-FLAG-EFABP (10
MOI), or coinfected with both adenoviruses. At 48 h postinfection, the
cells were treated with 0.3mM calcium chloride and 10 mM A23187
ionophore (Sigma) for up to 90min. Following treatment, the cells were
¢xed for 1h in 2% paraformaldehyde and permeabilized for 30min in
100% ice-cold methanol. The following primary and secondary
antibodies were used for detection: £uorescein isothiocyanate-conjugated
rat anti-HA (Roche, 1:50), Cy3-conjugated mouse anti-FLAG (Sigma,
1:100), rabbit anti-HA (Sigma-Aldrich, 1:100), mouse anti-a-actinin
(Sigma-Aldrich, 1:200), Cy3-conjugated sheep anti-mouse IgG (Sigma,
1:500), and AlexaFluor 488-conjugated goat anti-rabbit IgG (Molecular
Probes, 1:1000) (Molecular Probes, Eugene, OR, USA).
Confocal microscopy Keratinocytes were plated on 22 22mm glass
coverslips (Fisher Scienti¢c, Pittsburgh, PA, USA). The cells were infected
with Ad-HA-S100A7 (15 MOI) and 48 h postinfection the cells were
treated with 0.3mM Ca2þ and 10 mM A23187 ionophore for 60min.
Following treatment, the cells were ¢xed for 1h in 2% paraformaldehyde
and permeabilized for 30min in 100% ice cold methanol. The primary
antibodies used to costain the cells were rabbit anti-HA (Sigma; 1:100) and
either of the following antibodies from BD Transduction Laboratories
(Transduction Laboratories, San Diego, CA, USA) for di¡erent organelle
markers: mouse anti-BiP (1:50), mouse anti-LAMP1 (1:50), or mouse anti-
paxillin (1:500). Then the cells were incubated with the secondary
antibodies AlexaFluor488-conjugated goat anti-rabbit (Molecular Probes;
1:1000) and Cy3-conjugated sheep anti-mouse (Sigma; 1:500). Images were
analyzed using a confocal microscope equipped with an argon laser source
(model LSM510; Carl Zeiss).
Immunohistochemistry Uninvolved and involved psoriatic epidermis
was ¢xed overnight at 41C in 2% paraformaldehyde and sectioned.
Nonspeci¢c antibody binding was blocked by incubating sections for
30min at 251C with 1.5% serum (rabbit, S-5000; Vector Laboratories,
Burlingame, California). Blocked sections were then incubated with
preimmune serum or S100A7 isoform-speci¢c antibody (diluted 1:100 in
PBS) for 1h at 251C, rinsed with PBS, and incubated with biotin-labeled
secondary antibody (goat anti-rabbit IgG, Vector Laboratories) for 1 h at
251C in PBS. After washing, the sections were incubated for 30min with
avidin^biotin peroxidase complex. The sections were rinsed, stained with
3,30 -diaminobenzidine (SK-4100, Vectastain Kit) (Vector Laboratories,
Burlingame, CA, USA) and counterstained with hematoxylin.
RESULTS
S100A7/EFABP localization S100A7 and EFABP are highly
overexpressed in psoriatic tissue, but are not expressed in
undi¡erentiated cultured human keratinocytes. Thus, cultured
cells provide a useful null background in which to deliver
S100A7 and/or EFABP and to study their function. To express
these proteins, cells were infected with S100A7- or HA-EFABP-
encoding adenoviruses, and appearance of the corresponding
protein was monitored by immunoblot. As shown in Fig 1(A),
steady-state expression of S100A7 and HA-EFABP was observed
at 48 h.We next monitored the subcellular distribution of FLAG-
EFABP and HA-S100A7 using confocal microscopy. In cells
maintained in low calcium-containing medium, HA-S100A7
(green) and FLAG-EFABP (red) were distributed in the
cytoplasm with decreased staining towards the cell periphery
(Fig 1B, left panel). The combined image con¢rms this
colocalization (yellow). The enlarged orthogonal combined
image con¢rms colocalization in the cytoplasm of the cell
(white arrow), and also identi¢es a pool of S100A7 that is
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localized in perinuclear structures in the absence of EFABP
(green arrow).
S100A7 and EFABP interaction Based on previous reports by
Siegenthaler and coworkers (Hagens et al, 1999a, b), which
suggested that S100A7 and EFABP interact in psoriatic
epidermal extracts, we examined the interaction of S100A7 and
EFABP in cultured cells. Keratinocytes were infected with
HA-EFABP expressing adenovirus and incubated for 24 h. Cells
were then secondarily infected with increasing levels (MOI) of
empty adenovirus or S100A7 expressing adenovirus. The cells
were harvested at 48 h and EFABP level was measured. Figure
2(A) shows that S100A7 increases EFABP level across a range of
S100A7 concentrations. We con¢rmed this result in an inverse
experiment in which the cells initially expressed S100A7, and
were subsequently infected with empty virus or HA-EFABP
encoding virus (Fig 2B). These results suggest that S100A7 and
HA-EFABP stabilize one another. To determine whether this
e¡ect is speci¢c for S100A7, we measured the ability of HA-
EFABP to stabilize another S100 protein, S100A9. We ¢rst
con¢rmed that Ad5-S100A9 produces S100A9 in keratinocytes.
Cells were infected with Ad5-S100A9 or empty vector (Ad5-
EV). After 48 h, cells were harvested and assayed for S100A9
protein. Figure 2(C) shows that S100A9 is expressed. To
examine HA-EFABP e¡ects on S100A9 level, cells were infected
with S100A9 encoding adenovirus, followed 24 h later by
infection with empty virus or HA-EFABP producing virus.
After an additional 24 h, the cells were harvested and S100A9
level was assessed by immunoblot. Figure 2(D) shows that,
when normalized to b-actin, S100A9 levels are not increased
(stabilized) by HA-EFABP.
To study further S100A7/EFABP interaction, cells were
infected with Ad5-S100A7 and Ad5-HA-EFABP, and after 48 h
extracts were prepared for immunoprecipitation; however,
e¡orts to coprecipitate S100A7 and EFABP from these extracts
were not successful (not shown).We next repeated the infection
and at 48 h postinfection, treated cells for 60min with 1mM
DSS, a noncleavable bifunctional cross-linking agent. This agent
is widely used to cross-link closely juxtaposed proteins in cells.
Total extract (TE) and anti-HA immunoprecipitate (IP: a-HA)
were prepared and electrophoresed for immunoblot. As a
control to assure that HA-EFABP was precipitated, the blot
Figure1. Time course of HA-EFABP and S100A7 expression in ker-
atinocytes. (A) Near-con£uent (70%) cultures were infected with 15 MOI
of Ad5-S1007 or 10 MOI of Ad5-HA-EFABP at time 0 in medium con-
taining 0.09mM calcium. Whole cell extracts were prepared at the indi-
cated time points postinfection and S100A7 and HA-EFABP were
detected by immunoblot. b-actin serves as a control to normalize protein
loading and was detected using mouse anti-b-actin (Sigma, 1:10,000) fol-
lowed by horseradish peroxidase-conjugated sheep anti-mouse IgG (Amer-
sham, 1:10,000). (B) Keratinocytes were infected as in (A). After 48 h, the
cells were ¢xed, permeabilized, and HA-S100A7 and FLAG-EFABP were
detected by immuno£uorescence and visualized by confocal microscopy.
The left panels show single plane images (green, HA-S100A7; red, FLAG-
EFABP; yellow, combined), whereas the enlarged panel on the right shows
the combined orthogonal image.
Figure 2. Mutual stabilization of S100A7 and EFABP. (A) Stabiliza-
tion of HA-EFABP by S100A7. Cells were infected with 5 MOI of Ad5-
HA-EFABP at time 0, followed at 24 h by infection with the indicated
MOI of Ad5-S100A7. After an additional 24 h, extracts were prepared and
assayed for HA-EFABP level by immunoblot. (B) Stabilization of S100A7
by HA-EFABP. Cells were infected with 7 MOI of Ad5-S100A7 at time 0,
followed at 24 h by infection with the indicated MOI of Ad5-HA-EFABP.
After an additional 24 h, extracts were prepared and S100A7 level was as-
sayed by immunoblot. (C) Expression of S100A9 in keratinocytes. Fifty
percent con£uent keratinocyte cultures were infected at time 0 with 10
MOI of either Ad5-EV or Ad5-S100A9, and at 48 h postinfection whole
cells extracts were assayed for S100A9 by immunoblot. (D) EFABP does
not stabilize S100A9. Cells were infected with 10 MOI of Ad5-S100A9 at
time 0, followed at 24 h by infection with the indicated MOI of HA-
EFABP. After an additional 24 h, extracts were assayed for S100A9 level
by immunoblot. b-actin levels are shown as a control to normalize loading.
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shown in Fig 3(A) was incubated with anti-HA. HA-EFABP
monomer, as well as higher molecular weight cross-linked
species (asterisk), was detected in each sample, indicating that
anti-HA-EFABP precipitation was successful. To assess whether
S100A7 coprecipitates with HA-EFABP, a parallel blot was
incubated with anti-S100A7. As shown in Fig 3(B), S100A7
monomer and higher molecular weight immunoreactive species
(asterisk) were present in the TE. The anti-HA-EFABP-
precipitated sample (IP: a-HA) was enriched in high molecular
weight S100A7-immunoreactive material (Fig 3B, right panel),
indicating that S100A7 is associated with HA-EFABP. As
expected, S100A7 monomer was not precipitated. The double
asterisks indicate nonspeci¢cally precipitated bands. Neither
HA-EFAPB nor S100A7 is precipitated from cells infected with
empty virus (Fig 3A,B).
These ¢ndings were con¢rmed by the inverse experiment
showing that S100A7 precipitates EFABP. Cells were infected
with Ad5-FLAG-S100A7 and Ad5-HA-EFABP for 48 h, and
treated with or without DSS cross-linker for 60min. TE
and anti-FLAG-S100A7 immunoprecipitate (IP: a-FLAG) was
electrophoresed and prepared for immunoblot. The blot was
then incubated with anti-HA-EFABP. HA-EFABP was detected
in the TE, both as a monomer and as higher molecular weight
forms (Fig 3C, TE). HA-EFABP monomer would not be
expected to precipitate with FLAG-S100A7. No precipitation
was observed in cells infected with control empty virus.
We wanted to determine whether S100A7 and EFABP
monomer could be released from the high molecular weight
material shown in Fig 3(A^C). We expressed S100A7 and HA-
EFABP in keratinocytes. After 48 h, the cells were treated for
60min with 1mM DSP, a cleavable cross-linking agent. Extracts
were precipitated with anti-HA-EFABP, boiled with reducing
agent to cleave the cross-link, electrophoresed, and incubated
with antibodies speci¢c for HA-EFABP or S100A7 (Fig 4A).
The upper blot, incubated with anti-HA-EFABP, shows that
anti-HA precipitates HA-EFABP. The lower blot shows
that S100A7 can be released from the precipitated complex,
indicating that it coprecipitated with HA-EFABP. Precipitation
with nonspeci¢c antibody did not precipitate either protein (not
shown). The converse experiment is shown in Fig 4(B), and
con¢rms that HA-EFABP coprecipitates with S100A7.
Calcium treatment promotes S100A7 and EFABP
redistribution to peripheral structures As shown in Fig 1(B),
in cells maintained in low calcium medium, S100A7 and HA-
EFABP colocalize di¡usely throughout the cell cytoplasm. As
S100 proteins are activated by calcium (Heizmann and Cox,
1998), and calcium is a potent keratinocyte di¡erentiation
stimulus, we examined the e¡ects of calcium on S100 protein
subcellular localization.We used a classical method of increasing
intracellular calcium in keratinocytes in which cells are incu-
bated with calcium in the presence of ionophore (Green, 1980).
Figure 5(A) (0min) shows that in cells grown in 0.09mM
calcium-containing medium, S100A7 and EFABP colocalize in
the cytoplasm. Shifting the cells to medium containing 0.3mM
calcium and 10mM A23187 results the formation of peripheral
structures that appear as dark spots in bright ¢eld images
(Fig 5A, arrows). Both S100A7 and EFABP are enriched in these
structures (arrows). At lower magni¢cation (Fig 5B), it is possible
to determine that these structures form in 28% of cells at 60min
after calcium/A23187 treatment (arrows). Figure 5(C) shows that
S100A7 and EFABP also distribute to these structures when
expressed alone, indicating that this distribution does not require
that both proteins be present. Based on the cell culture results
presented above, we hypothesized that S100A7 might distribute
to the plasma membrane in vivo. Indeed, staining of normal
epidermis with anti-S100A7 shows a di¡use distribution in basal
cells with progressively more peripheral S100A7 localization in the
high suprabasal layers. A similar pattern is observed in psoriatic
epidermis, except that the peripheral localization is more
dramatic (Fig 6).
S100A7 redistribution in cultured keratinocytes We used
confocal microscopy to examine the redistribution in cultured
Figure 3. Co-precipitation of S100A7 and HA-EFABP. (A) Keratino-
cytes were infected with 25 MOI of Ad5-EV, 15 MOI Ad5-S100A7, or 10
MOI of Ad5-HA-EFABP for 48 h. Cells were subsequently treated with
DSS cross-linker. TE or anti-HA immunoprecipitate were electrophoresed
and HA-EFABP was detected by immunoblot. High molecular weight
HA-EFABP containing complexes are indicated by the asterisk. (B) An
identical parallel blot to that shown in the above panel was incubated with
anti-S100A7. High molecular weight complexes containing S100A7 are in-
dicated by the asterisk. Double asterisks indicate nonspeci¢c bands. (C)
Keratinocytes were infected with 25 MOI of Ad5-EV, 15 MOI of Ad5-
FLAG-S100A7, or 10 MOI of Ad5-HA-EFABP for 48 h.TE and anti-FLAG
immunoprecipitate were electrophoresed and HA-EFABP was detected by
immunoblot. HA-EFABP migrates as a higher molecular weight complex
marked by the asterisk. Details are provided in Materials and Methods.
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cells in greater detail. As shown in Fig 1(B), in cells maintained
in low calcium conditions, S100A7 and HA-EFABP colocalize in
the perinuclear cytosol. In addition, perinuclear structures stain
exclusively for S100A7 (see Fig 1B). Treatment with 0.3mM
calciumþ10 mM A23187 results in a substantial redistribution of
both HA-S100A7 (green) and FLAG-EFABP (red) to peripheral
structures (Fig 7). The combined image (yellow) shows
substantial colocalization of S100A7 and EFABP in these
structures. An enlarged orthogonal image is shown on the right.
The domains are actually protrusions extending downward from
the cell surface. The yellow color indicates the presence of both
HA-S100A7 and FLAG-EFABP. In addition, EFABP-negative/
S1007-positive perinuclear vesicular staining is also observed in
0.3 mM calcium/A23187-treated cells (green arrows).
S100A7 colocalizes with a-actinin To learn more about
the cell periphery structures, cells were infected with
Ad5-S100A7, treated for 60 min with calcium, and then
costained with anti-HA-S100A7 and anti-a-actinin (Fig 8). The
a-actinin (red) and HA-S100A7 (green) images indicate that
both proteins are present in these structures and the combined
image (yellow) indicates that they colocalize. The orthogonal
combined confocal image (right panel) shows that S100A7
and a-actinin colocalize in the peripheral structures (white
arrows). Additional studies con¢rm that EFABP also colocalizes
at these sites (not shown). This image also shows that a-actinin
is not present with S100A7 in the perinuclear vesicles (green
arrows).
Localization with other markers To assign further the
location of S100A7, cells maintained in 0.09mM calcium or
0.3mM calcium/A23187, were costained for S100A7 and markers
associated with various subcellular organelles (Fig 9). BiP/GRP78
is a marker of endoplasmic reticulum (Rao et al, 2002). Our
analysis shows that in control cells, some of the S100A7 localizes
with BiP/GRP78 in perinuclear tubular endoplasmic reticulum-
like structures. Upon treatment with calcium and ionophore, the
endoplasmic reticulum fragments into vesicles. Some of these
vesicles stain with BiP, some stain with S100A7, and some stain
for both (see insert). In addition, a strong colocalization of
S100A7 and paxillin, a focal adhesion organizing protein (Lin
et al, 1995), is observed in calcium/A23187-treated cells. This
¢nding is consistent with the colocalization of S100A7 with a-
actinin shown in Fig 8, as paxillin and a-actinin are known to
participate in complex formation in focal adhesions. In contrast,
S100A7 does not localize with LAMP-1, a late endosomal/
lysosomal marker (Karlsson and Carlsson, 1998), suggesting that
it is not being targeted for degradation.
Kinase and phosphatase regulators in£uence S100A7/EFABP
redistribution The above results show that calcium promotes
redistribution of S100A7 and EFABP. To examine further the
regulation of redistribution, we expressed HA-S100A7 and
FLAG-EFABP, and then treated with 12-O-tetradecanoyl-
phorbol-13-acetate or okadaic acid for 60 min. 12-O-
tetradecanoyl-phorbol-13-acetate did not cause redistribution of
S100A7 or EFABPboth remained colocalized in a perinuclear
region (nucleus is circled) (Fig 10). In contrast, treatment with
okadaic acid caused rapid redistribution of both proteins to cell
periphery structures (arrows).
DISCUSSION
S100 proteins in epidermis S100 proteins comprise a 16
member multigene family that encode calcium-activated
signaling proteins (Donato, 2001). S100 proteins exist as dimers
in cells (Donato, 2001), and each monomer contains two
calcium-binding EF-hand motifs (Schafer and Heizmann, 1996).
These motifs are separated by a £exible hinge region, and
£anked by hydrophobic regions (Schafer and Heizmann, 1996).
The C-terminal EF-hand is a canonical calcium-binding loop
containing 12 amino acids, whereas the N-terminal motif is a
noncanonical calcium-binding motif that includes 14 amino
acids and has a lower a⁄nity for calcium (Krebs et al, 1995). It
has been proposed that increased intracellular calcium causes a
change in S100 dimer conformation and permits the dimer to
interact with target protein(s). This interaction then alters target
protein function to produce a biologic response. Thus, two
important goals are identi¢cation of S100 target proteins and
sites of intracellular action (Heizmann and Cox, 1998). At least
six members of this multiprotein family are expressed in
epidermis, including S100A2, S100A7, S100A8, S100A9, S100A10,
and S100A11 (Boni et al, 1997; Robinson et al, 1997; Donato, 2001).
Expression of selected S100 proteins is increased in epidermal
disease. For example, S100A7, S100A8, and S100A9 are
overexpressed in psoriasis (Madsen et al, 1991; Saintigny et al,
1992). S100A7 expression is also markedly increased in other
hyperproliferative skin diseases, including atopic dermatitis,
mycosis fungoides, and Darier’s disease (Madsen et al, 1991;
Algermissen et al, 1996). These ¢ndings indicate that S100A7 is a
marker of these diseases, and also suggest a potentially important,
but unproven, role for S100A7 in the genesis and/or maintenance
of skin disease.
Evidence for intracellular interaction of S100A7 and
EFABP Previous studies using extracts prepared from
psoriatic-involved epidermis provided an important clue that
epidermal fatty acid binding protein might be an S100A7 target
(Hagens et al, 1999a, b). Interestingly, like S100A7, EFABP is
expressed at low levels in normal skin but is overexpressed in
psoriatic epidermis (Madsen et al, 1992; Siegenthaler et al, 1993,
1994). To study this interaction in cultured keratinocytes, we
Figure 4. Release of coprecipitated S100A7 and HA-EFABP mono-
mers. Keratinocytes were infected with 15 MOI of Ad5-S100A7, 25 MOI
of Ad5-EV, or 10 MOI of Ad5-HA-EFABP as indicated for 48 h. The cells
were then incubated for 1h with 1mM of cleavable DSP cross-linker and
extracts were prepared in reducing agent-containing gel bu¡er to cleave
the DSP-dependent cross-link. A Immunoprecipitation with anti-HA, fol-
lowed by electrophoresis and blotting with anti-HA or anti-A7. (B) Immu-
noprecipitation with anti-A7 followed by electrophoresis and blotting with
anti-A7 or anti-HA. Co-immunoprecipitation was not observed when pro-
tein cross-linker treatment was omitted (not shown).
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expressed S100A7 and EFABP in cultured human keratinocytes.
Initial microscopic studies showed that the expressed S100A7
and EFABP proteins colocalize in cells. Subsequent biochemical
studies show that increased S100A7 expression results in increased
levels of EFABP and vice versasuggesting a stabilizing
interaction. This e¡ect was speci¢c for S100A7, as a similar
increase in S100A9, another S100 protein overexpressed in
psoriatic epidermis (Siegenthaler et al, 1997), was not observed in
the presence of EFABP. Characterization of FLAG-S100A7-
associated complexes in human cultured keratinocytes using a
Figure 5. HA-S100A7 and FLAG-EFABP distribution in calcium-treated cells. (A) Keratinocytes were infected with 15 MOI Ad5-HA-S100A7 and
10 MOI of Ad5-FLAG-EFABP. At 48 h postinfection, keratinocytes were treated with 0.3mM calcium and 10 mMA23187 for 0, 20, and 60min. HA-S100A7
(green) and FLAG-EFABP (red) were detected by £uorescence microscopy.The S100A7/EFABP column shows the combined green and red imagesyellow
indicates colocalization. The arrows indicate localization of S100A7 and EFABP in peripheral structures. (B) Cells were infected with 15 MOI Ad5-HA-
S100A7. After 48 h, the cells were treated for 0 or 60min in 0.3mM calcium/10 mM A23187-containing medium, ¢xed and stained with anti-S100A7.
S100A7 redistributed (e.g., arrows) in 28% of the cells at 60min of treatment (calculated as an average ¢ve representative ¢elds, 40 objective). (C) Cells
were infected with HA-S100A7 encoding adenovirus (left panels) or FLAG-EFABP encoding adenovirus (right panels). After a 60min treatment with
0.3mM calcium/A23187 cells were ¢xed and stained, respectively, with anti-HA (green) or anti-FLAG (red).
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cell membrane-permeable noncleavable cross-linker (DSS)
followed by immunoprecipitation with anti-FLAG, revealed
high molecular weight protein complexes containing HA-
EFABP. Likewise, precipitation of HA-EFAPB resulted in
S100A7 coprecipitation. These studies suggest a speci¢c S100A7/
EFABP interaction. Although we believe that it is a
physiologically important interaction, it may be a transient
interaction, as we do not observe coprecipitation of S100A7-
EFABP complexes in cells not treated with cross-linking agent.
These ¢ndings contrast slightly with those of Siegenthaler and
coworkers (Hagens et al, 1999a) who reported that S100A7 and
EFABP formed a complex that could be precipitated without
addition of cross-linker (Hagens et al, 1999a); however, these
investigators prepared precipitates directly from psoriatic tissue
and not from cultured cells. Thus, it is possible that these
proteins are modi¢ed in vivo, or an additional protein is
expressed in vivo that is important for stabilizing the complex. In
fact, two forms of S100A7 have been reported that may represent
conformational variants and it has been speculated that one of
these forms may have a reduced ability to interact with EFABP
(Burgisser et al, 1995). Moreover, it has been reported that Zn2þ
ion can cause the complex to dissociate (Hagens et al, 1999a), thus
it is possible that the ion sensitivity may di¡er in cultured cells;
however, on balance, our studies and those of Siegenthaler and
Figure 6. Distribution of S100A7 in normal and psoriatic epider-
mis. Sections from uninvolved (normal epidermistop panels) and in-
volved (psoriatic epidermisbottom panels) were incubated with
preimmune or anti-S100A7 (see Materials and Methods). The arrows indicate
areas of S100A7 at the cell periphery. The dashed line traces the basal lami-
na. Scale bars¼ 20 mm. The staining of the corni¢ed layer is nonspeci¢c.
Figure 7. Confocal imagescalcium mobilization of HA-S100A7
and FLAG-EFABP. Keratinocytes were infected with 15 MOI Ad5-HA-
S100A7 and 10 MOI of Ad5-FLAG-EFABP and maintained in low calcium
(0.09mM) containing medium. At 48 h postinfection, keratinocytes were
treated with 0.3mM calcium and 10mM A23187 for 60min. Following
¢xation and permeabilization, HA-S100A7 (green) and FLAG-EFABP
(red) were detected by immuno£uorescence and the images were visualized
using confocal imaging. The white arrows indicate HA-S100A7 and FLAG-
EFABP colocalization in plasma membrane structures that make contact
with the underlying substratum following calcium/A23187 treatment. The
green arrows identify S100A7-enriched intracellular vesicles, and the red arrow
indicates EFABP peripheral structures, white arrows indicate S100A7/EFABP
colocalization.
Figure 8. Confocal imagescolocalization of HA-S100A7 and a-
actinin in calcium-treated cells. Keratinocytes were infected with 15
MOI Ad5-HA-S100A7 and at 48 h postinfection were treated with
0.3mM calcium/10 mM A23187 for 60min. Following ¢xation and per-
meabilization, HA-S100A7 (green) was detected by immuno£uorescence.
In addition, the cells were costained to detect a-actinin (red). The picture
composite shows individual a-actinin and HA-S100A7 distribution, and
the combined (a-actinin/HA-S100A7) image in cells maintained in high
calcium. The accompanying orthogonal projection of the combined image
is shown at the right. The white arrows indicate a-actinin and HA-S100A7
colocalization in peripheral structures. The green arrows indicate S100A7-en-
riched intracellular vesicles, and the red arrow indicates a-actinin in periph-
eral structures.
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colleagues (Hagens et al, 1999a,b) suggest that S100A7 and EFABP
are part of a common complex.
S100A7 and EFABP localization and stimulus-dependent
redistribution Intracellular localization and distribution are
important determinants of protein function. Thus, it is
important to identify the intracellular compartment that hosts
the presence of S100A7 and EFABP, and whether di¡erentiating
agents regulate their distribution. In resting cells, S100A7 and
EFABP are codistributed in the cytoplasm. Treatment with
calcium, a keratinocyte-di¡erentiating stimulus (Rice and
Green, 1979; Hawley-Nelson et al, 1980; Tsao et al, 1982), results in
the redistribution of cytosolic S100A7 and EFABP to de¢ned
structures at the cell periphery. These peripheral structures share
properties with focal adhesion plaques, including being enriched
in paxillin (Petit andThiery, 2000;Wade et al, 2002) and a-actinin
(Petit and Thiery, 2000; Edlund et al, 2001). The ¢nding that
S100A7 is associated with the cell periphery in calcium-treated
cultured cells is consistent with a previous demonstration that
S100 proteins are covalently cross-linked components of the
corni¢ed envelope (Robinson et al, 1997), and the observation
that S100A7 appears to redistribute from the cytosol to the cell
periphery during in vivo epidermal di¡erentiation (Fig 6). These
¢ndings contrast with a previous report indicating that S100A7
remains di¡usely distributed in all epidermal layers in psoriasis
(Hagens et al, 1999a). The explanation for this di¡erence is not
clear; however, di¡erent antibodies were used for detection in
each case.
In addition to the cytoplasmic localization in resting cells,
some S100A7 is also present in a perinuclear location in the
endoplasmic reticulum. It is not clear why some of the S100A7
is maintained in the endoplasmic reticulum and the remainder is
present in the cytoplasm; however, two forms of S100A7 have
been reported (Burgisser et al, 1995) and these may represent the
material we ¢nd distributed in the two compartments. Upon
calcium treatment the endoplasmic reticulum dissociates into
vesicles (Subramanian and Meyer, 1997) and the endoplasmic
reticulum-localized S100A7 is retained in these vesicles.
Identifying the function of this pool of S100A7 will require
additional study.
Functional role of S100A7 Based on these and previously
published studies, we can construct a model outlining possible
functions of S100A7 in keratinocytes. The present studies clearly
show that S100A7 (and EFABP) move to the cell periphery after
stimulation of keratinocytes with prodi¡erentiation agents. Thus,
we hypothesize that the vicinity of the plasma membrane is an
ultimate site of S100A7 action. This idea is supported by several
observations. First, S100A7 is a transglutaminase substrate (Ruse
et al, 2001) suggesting that it may be a component of the
keratinocyte corni¢ed envelopeas are other S100 proteins
(Robinson et al, 1997; Robinson and Eckert, 1998). To function as
such it would need to come in contact with the plasma
membrane. Second, S100A7 is known to be secreted and to
function as a chemokine (Madsen et al, 1991; Jinquan et al, 1996;
Watson et al, 1998), thus, redistribution to the plasma membrane
may be a necessary step for export. Third, S100A7 decorates the
cell surface in di¡erentiated normal keratinocytes and psoriatic
tissue (Fig 6). Fourth, S100A7 is localized with proteins that
comprise the focal adhesions, including paxillin and a-actinin
(Figs 8 and 9). These results suggest that S100A7 may function
as a shuttle protein to move other proteins, including EFABP, to
the cell periphery. Moreover, the association with focal adhesion
markers suggests that it may play a part in regulating adhesion,
and perhaps motility, during disease, metastasis, and wound
healing (Ben Ze’ev et al, 1994; Newell et al, 1999; Kim et al, 2001).
The role of EFABP as an S100A7 target, and its role in focal
adhesion-like structures are not known; however, EFABP does
bind to oleic acid (Hagens et al, 1999b). Thus, S100A7 and
EFABP could function to transport and/or metabolize fatty
acids, including oleic acid (Hagens et al, 1999b). Other S100
proteins have also been implicated in fatty acid processing,
including S100A8 and S100A9 (Kragballe and Voorhees, 1987;
Fogh et al, 1989; Siegenthaler et al, 1997).
Kinase regulation of S100A7 and EFABP distribution In
addition to calcium, we also assessed the e¡ect of other
keratinocyte di¡erentiating agents on S100A7 and EFABP
distribution. Interestingly, redistribution of S100A7 and EFABP
to peripheral structures was observed when keratinocytes were
treated with okadaic acid but not with 12-O-tetradecanoyl-
phorbol-13-acetate. This suggests that translocation of S100A7
and EFABP is dependent upon phosphatase/kinase activity, but
that the kinase is not protein kinase C. The okadaic acid results
suggest that translocation may be modulated by protein
phosphatase 1 and 2A. Alternatively, the process may be
controlled by a kinase that is modi¢ed by these phosphatases. In
agreement with this suggestion, previous studies show that
S100A8 and S100A9 translocation in activated neutrophils and
Figure 9. Subcellular localization of HA-S100A7 and markers of in-
tracellular compartments. Keratinocytes were infected with 15 MOI
Ad5-HA-S100A7 and at 48 h postinfection were treated with 0.09mM cal-
cium (Control) or 0.3mM calcium/10 mM A23187 for 60min. Following
¢xation and permeabilization, slides were stained with rabbit anti-HA-
S100A7 (green). In addition, the slides were stained with mouse anti-BiP/
GRP78, anti-LAMP1 or anti-paxillin (red). Green arrows indicate HA-
S100A7 immuno£uorescence, red arrows indicate the presence of the respec-
tive marker protein, and yellow arrows indicates colocalization of HA-
S100A7 with the marker. The images were obtained using confocal micro-
scopy. The circles indicate the location of peripheral structures.
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monocytes requires extracellular calcium, and that it may be
phosphorylation dependent (Guignard et al, 1996; van den et al,
1996). Moreover, it has been suggested that a kinase other than
protein kinase C might be involved in the calcium-activated
signaling that leads to S100A8 and S100A9 translocation
(Guignard et al, 1996). Additional studies will be required to
identify these regulators.
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